论文部分内容阅读
作者在本文报告了用 cerocral 治疗脑神经外科范围的眩晕症20例,其中包括头部受伤的10例,以脑为主的中枢神经系统供血不足(包括脑动脉硬化症、高血压症、一过性脑缺血、低血压症、脑栓塞症引起的眩晕)10例。年龄20～70(平均48.4)岁。男15,女5例。患者每日服 cerocral 3片,观察2～11周。cerocral 的分子式为(C_(21)H_(27)NO_2)_2·C_4H_6O_6。一般认为本药有增加脑血流量、改善脑代谢及抑制血小板凝集的功能,主要是增加椎-基底动脉血流量。其机制是直接扩张血管平滑肌,抑制交感神经α受体的异常兴奋,另外还有轻度抗组织胺及抗5-羟色胺作用。结果 20例中疗效显著3例,有效7例,微效4倒,无效6例。均无副作用。疗效显著的1例是旋转性眩晕,另2例是浮动感或摇动感眩晕。有效的7例
The authors report in this paper 20 cases of vertigo associated with cerocral for the treatment of neurosurgical neurology, including 10 cases of head injury, insufficiency of brain-based central nervous system (including cerebral arteriosclerosis, hypertension, Cerebral ischemia, hypotension, dizziness caused by cerebral embolism) in 10 cases. Age 20 ~ 70 (average 48.4) years old. Male 15, female 5 cases. Patients daily serving cerocral 3 tablets, observed 2 to 11 weeks. The formula of cerocral is (C_ (21) H_ (27) NO_2) _2 · C_4H_6O_6. Generally believed that the drug has increased cerebral blood flow, improve brain metabolism and inhibit platelet aggregation function, mainly to increase vertebrobasilar blood flow. The mechanism is a direct expansion of vascular smooth muscle, inhibiting sympathetic α receptor abnormal excitement, in addition to mild antihistamine and anti-serotonin effect. Results The curative effect of 20 cases was significant in 3 cases, effective in 7 cases, 4 cases of ineffective, ineffective in 6 cases. No side effects. One case of significant effect is rotational dizziness, the other two cases are floating sense or shaking sense of dizziness. Effective in 7 cases